Oppenheimer & CO Inc Chroma Dex Corp. Transaction History

Oppenheimer & CO Inc

$6.42 Billion
Q3 2024

A detailed history of Oppenheimer & CO Inc transactions in Chroma Dex Corp. stock. As of the latest transaction made, Oppenheimer & CO Inc holds 16,900 shares of CDXC stock, worth $125,736. This represents 0.0% of its overall portfolio holdings.

Number of Shares

16,900

Previous 16,900 -0.0%

Holding current value

$125,736

Previous $46,000 32.61%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$2.44 - $4.32 $6,588 - $11,664	-2,700 Reduced 13.78%	16,900 $46,000
Q1 2024 May 06, 2024	SELL	$1.36 - $3.84 $10,880 - $30,720	-8,000 Reduced 28.99%	19,600 $68,000
Q1 2023 May 10, 2023	SELL	$1.48 - $2.19 $3,700 - $5,475	-2,500 Reduced 8.31%	27,600 $42,000
Q4 2022 Feb 07, 2023	SELL	$1.25 - $1.94 $125 - $194	-100 Reduced 0.33%	30,100 $50,000
Q3 2022 Nov 14, 2022	SELL	$1.19 - $2.06 $10,602 - $18,354	-8,910 Reduced 22.78%	30,200 $37,000
Q2 2022 Aug 08, 2022	BUY	$1.59 - $2.7 $34,821 - $59,130	21,900 Added 127.25%	39,110 $65,000
Q1 2022 May 12, 2022	SELL	$2.02 - $3.92 $15,958 - $30,968	-7,900 Reduced 31.46%	17,210 $42,000
Q4 2021 Feb 02, 2022	BUY	$3.74 - $6.7 $10,846 - $19,430	2,900 Added 13.06%	25,110 $94,000
Q2 2021 Aug 03, 2021	BUY	$6.66 - $10.92 $17,316 - $28,392	2,600 Added 13.26%	22,210 $219,000
Q1 2021 May 10, 2021	SELL	$4.59 - $18.74 $17,901 - $73,086	-3,900 Reduced 16.59%	19,610 $183,000
Q4 2020 Feb 11, 2021	BUY	$3.93 - $5.5 $92,394 - $129,305	23,510 New	23,510 $113,000
Q1 2019 Apr 24, 2019	SELL	$3.2 - $4.19 $160,000 - $209,500	-50,000 Closed	0 $0
Q4 2018 Jan 29, 2019	SELL	$2.8 - $4.22 $118,999 - $179,350	-42,500 Reduced 45.95%	50,000 $172,000
Q1 2018 May 01, 2018	BUY	$4.05 - $6.46 $202,500 - $323,000	50,000 Added 117.65%	92,500 $389,000
Q4 2017 Feb 07, 2018	BUY	$3.88 - $6.96 $164,900 - $295,800	42,500	42,500 $250,000

Others Institutions Holding CDXC

# of Institutions

Shares Held

17.2M

Call Options Held

66.7K

Put Options Held

8.2K

View Full List

About ChromaDex Corp.

Ticker CDXC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,350,896
Market Cap $509M
Description
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...

More about CDXC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer & CO Inc with notifications on news.

Account

Oppenheimer & CO Inc Chroma Dex Corp. Transaction History